NEWS

Lou Hawthorne to speak at Rejuvenation Startup Summit 2022

Lou Hawthorne

We are happy to announce Lou Hawthorne, Founder and CEO of NaNotics LLC as a speaker for the Rejuvenation Startup Summit 2022.

NaNotics LLC is a mature preclinical stage company based in Mill Valley, CA, just north of San Francisco. The company has 12 granted patents on its NaNot™ nano-depletion platform with many more patents pending. The company is developing a pipeline of eight NaNots™ against a range of inflammatory and inhibitory targets driving multiple diseases representing significant unmet medical need.

Read More

Phil Newman to speak at Rejuvenation Startup Summit 2022

Phil Newman

We are happy to announce Phil Newman, Founder and CEO of Longevity.Technology as a speaker for the Rejuvenation Startup Summit 2022.

Phil will speak about ‘The longevity investment landscape’. He will cover the mapping of longevity domains and categories, key areas attracting investment; the clinical stages of longevity biotechs, the funding stages of longevity biotechs, and give an outlook for longevity investing.

Read More

Join leading VCs at the largest gathering of longevity CEOs at the Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) in-person

Rejuvenation Startup Summit

The Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) is a vibrant in-person networking event that brings together startups and members of the longevity venture capital/investor ecosystem – all aiming to create therapies to vastly extend the healthy human lifespan. Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself.

In addition to an exciting range of presentations from CEOs of startups in the field of rejuvenation/longevity, the summit features an all-day startup forum for vibrant networking. Starting midday on Friday and finishing off on Saturday night with a big party, it offers ample opportunity to get in touch, learn and network with leading VCs and investors in the field like:

– Christian Angermayer, Founder of the Apeiron Investment Group, Co-founder and chairman of Rejuveron and Cambrian Bio
– Dr. Alexandra Bause, Co-Founder, Investment Director, and Head of VentureLabs at Apollo Health Ventures
– Dr. Tobias Reichmuth, Founding Partner at Maximon – The Longevity Company Builder
– Dr. Stephen Helliwell, Vice President Discovery Biology at Rejuveron Life Sciences
– Dr. Michael Sidler, Co-Founding Partner at Redalpine Venture Partners
– Patrick Burgermeister, Partner at Kizoo Technology Capital

Startups learn from the leading investors in the longevity space and get them interested in their approach or connect to potential new team members.

Investors, if new to the field, get jumpstarted on the upcoming new megatrend ‘Rejuvenation/Longevity’ – a still-young industry that will eventually become much bigger than today’s largest technology markets.

Read More

Eric Verdin and Brian Kennedy to speak at Rejuvenation Startup Summit 2022

Eric Verdin and Brian Kennedy

Berlin/Germany, July 5, 2022 – We are happy to announce two eminent speakers will present at the Rejuvenation Startup Summit 2022 in Berlin: Eric Verdin, President and CEO of the Buck Institute for Research on Aging and Brian Kennedy, Professor at the National University Singapore (NUS), as keynote speakers for the Rejuvenation Startup Summit 2022.

Eric and Brian will introduce the various initiatives at the Buck and at NUS, respectively, to help teams “breaking out of the lab” and founding rejuvenation/longevity startups.

Read More

Dr. Alexander Schueller to speak at Rejuvenation Startup Summit 2022

Alex Schueller

We are happy to announce Dr. Alexander Schueller, CEO of CellVie, as a speaker for the Rejuvenation Startup Summit 2022. Also meet Scientific Co-Founders Prof. Dr. James McCully, who invented the approach of Therapeutic Mitochondria Transplantation (TMT) and Dr. Sitaram Emani, having been the first to employ TMT clinically at Boston Children’s Hospital.

Cellvie is a Harvard spin-off pioneering Therapeutic Mitochondria Transfer (TMT) leveraging the therapeutic potential of mitochondria.

The company was founded by Drs. McCully, Schueller, del Nido and Emani. Dr. McCully pioneered the approach of mitochondria augmentation and replacement at Harvard Medical School and the team has now set out to bring it about as a new treatment modality in ischemia-reperfusion injury and beyond to slow or reverse degenerative processes of aging linked to the mitochondria.

Read More

Join the largest gathering of longevity CEOs in-person

The Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) is a vibrant networking event that brings together startups and members of the longevity venture capital/investor ecosystem – all aiming to create therapies to vastly extend the healthy human lifespan. Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself.

In addition to an exciting range of presentations from CEOs of startups in the field of rejuvenation/longevity, the summit features an all-day startup forum for vibrant networking. Starting midday on Friday and finishing off on Saturday night with a big party, it offers ample opportunity to get in touch, learn and network with some of the most promising companies in the field.

Investors may explore concrete investment opportunities, or – if new to the field, get jumpstarted on the upcoming new megatrend ‘Rejuvenation/Longevity’ – a still young industry that will eventually become much bigger than today’s largest technology markets.

Read more to see list of CEOs…

Read More

Alex Blyth to speak at Rejuvenation Startup Summit 2022

Alex Blyth

We are happy to announce Alex Blyth, Founder and CEO of LIfT BioSciences, as a speaker for the Rejuvenation Startup Summit 2022. Also meet Dr. Oxana Polyakova, LIfT’s CSO at the networking forum of the summit.

LIfT BioSciences is committed to developing the world’s first ‘off-the-shelf’ cell therapy to destroy all solid tumours, irrespective of strain or mutation. LIfT is currently completing pre-clinical work before running a first-in-human clinical trial to demonstrate remission in high unmet need solid tumours by 2023, including pancreatic cancer.

Read More

Dr. Matthias Breugelmans to speak at Rejuvenation Startup Summit 2022

We are happy to announce Dr. Matthias Breugelmans, CEO of Elastrin Therapeutics, as a speaker for the Rejuvenation Startup Summit 2022. Also meet Dr. Naren Vyavahare at the networking forum of the summit. Naren is Elastrin’s CSO and Prof. at Clemson University, where the technology was first developed over a 20-year period.

Elastrin Therapeutics is a biotechnology company leveraging a platform to develop therapeutics that render calcified tissue and organs supple again. Elastrin Therapeutics was founded in 2018 as a spin-out from Clemson University. The company recently announced it will start clinical trails in 2023.

Read More